Synergistic interactions of repurposed drugs that inhibit Nsp1, a major virulence factor for COVID-19

Hung-Teh Kao1, Andrew Orry2, Michael G Palfreyman3

  • 1Sypherion LLC, Providence, RI, 02903, USA. htkao@SypherionBio.com.

Scientific Reports
|June 17, 2022
PubMed

Insights

Scientists developed a new assay to detect the action of SARS-CoV-2

Area of Science:

  • Virology
  • Molecular Biology
  • Drug Discovery

Background:

  • The SARS-CoV-2 Nsp1 protein is a key virulence factor in COVID-19 pathogenesis.
  • Nsp1 interferes with host cell functions, contributing to disease severity.

Purpose of the Study:

  • To develop a novel assay for detecting Nsp1 activity in cultured lung cells.
  • To identify existing drugs that can inhibit Nsp1's detrimental effects.
  • To discover synergistic drug combinations for COVID-19 treatment.

Main Methods:

  • Development of a rapid multiplexed assay based on Nsp1-induced cytopathic effects.
  • Virtual screening of compounds targeting Nsp1's RNA-binding groove and C-terminal region.
  • Experimental screening of drug-repurposing candidates and their combinations.

Main Results:

  • Identification of multiple synergistic compound combinations that inhibit Nsp1 activity.
  • Ponatinib, Rilpivirine, and Montelukast demonstrated significant inhibition of Nsp1.
  • This combination reversed Nsp1's toxic effects comparably to genetic Nsp1 inactivation.

Conclusions:

  • A novel assay effectively measures Nsp1 activity and identifies inhibitors.
  • Drug repurposing strategies can yield effective combinations against Nsp1.
  • Ponatinib, Rilpivirine, and Montelukast represent a promising therapeutic combination for COVID-19.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.7K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.2K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
156
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
91